35 related articles for article (PubMed ID: 21485025)
1. Additional slides from residual ThinPrep Pap tests: Of potential diagnostic benefit in equivocal cases?
Grapsa D; Ioakim-Liossi A; Stergiou E; Petrakakou E; Nicolopoulou-Stamati P; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2012 Oct; 40(10):856-60. PubMed ID: 21485025
[TBL] [Abstract][Full Text] [Related]
2. Repeat processing of residual ThinPrep Pap tests: sampling of the vial may not be invariably homogeneous.
Grapsa D; Ioakim-Liossi A; Stergiou E; Petrakakou E; Nicolopoulou-Stamati P; Patsouris E; Athanassiadou P
Acta Cytol; 2011; 55(2):213-7. PubMed ID: 21325810
[TBL] [Abstract][Full Text] [Related]
3. Resolving ASCUS without recourse to HPV testing: manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC).
Maksem JA; Bedrossian CW; Kurtycz D; Sewall S; Shalkham J; Dhanwada V; Lind H; Bibbo M; Weidmann J; Kane B; Shi Fu Y
Diagn Cytopathol; 2005 Dec; 33(6):434-40. PubMed ID: 16299747
[TBL] [Abstract][Full Text] [Related]
4. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
5. Repeating cytological preparations on liquid-based cytology samples: A methodological advantage?
Pinto AP; Maia HF; di Loretto C; Krunn P; Túlio S; Collaço LM
Diagn Cytopathol; 2007 Oct; 35(10):663-9. PubMed ID: 17854084
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the ThinPrep monolayer technique and conventional cervical Pap smears in a high-risk population using the Munich II nomenclature].
Lellé RJ; Cordes A; Regidor M; Maier E; Flenker H
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):81-7. PubMed ID: 17440269
[TBL] [Abstract][Full Text] [Related]
7. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method.
Moore GD; Lear SC; Wills-Frank LA; Martin AW; Snyder JW; Helm CW
Diagn Cytopathol; 2005 Feb; 32(2):82-7. PubMed ID: 15637682
[TBL] [Abstract][Full Text] [Related]
9. Invasive squamous-cell carcinoma in ThinPrep specimens: diagnostic clues in the cellular pattern.
Clark SB; Dawson AE
Diagn Cytopathol; 2002 Jan; 26(1):1-4. PubMed ID: 11782077
[TBL] [Abstract][Full Text] [Related]
10. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
11. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
[TBL] [Abstract][Full Text] [Related]
12. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
[TBL] [Abstract][Full Text] [Related]
13. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
14. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
Howell LP; Gurusinghe S; Tabnak F
Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cellular residue in the ThinPrep PreservCyt vial.
Massarani-Wafai R; Bakhos R; Wojcik EM; Selvaggi SM
Diagn Cytopathol; 2000 Sep; 23(3):208-12. PubMed ID: 10945912
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ.
Roberts JM; Thurloe JK; Bowditch RC; Humcevic J; Laverty CR
Acta Cytol; 1999; 43(1):74-80. PubMed ID: 9987454
[TBL] [Abstract][Full Text] [Related]
17. An Australian trial of ThinPrep: a new cytopreparatory technique.
Laverty CR; Thurloe JK; Redman NL; Farnsworth A
Cytopathology; 1995 Jun; 6(3):140-8. PubMed ID: 7669924
[TBL] [Abstract][Full Text] [Related]
18. Utility of additional slides from residual Preservcyt material in difficult ThinPrep gynecologic specimens: a prospective study of 58 cases.
Hoerl HD; Wagner JL; De Las Casas LE; Shalkham JE; Hafez GR; Kurtycz DF
Diagn Cytopathol; 2001 Aug; 25(2):141-7. PubMed ID: 11477723
[TBL] [Abstract][Full Text] [Related]
19. BestCyte® Cell Sorter Imaging System: Primary and adjudicative whole slide image rescreening review times of 500 ThinPrep Pap test thin-layers - An intra-observer, time-surrogate analysis of diagnostic confidence potentialities.
Chantziantoniou N
J Pathol Inform; 2022; 13():100095. PubMed ID: 36268084
[TBL] [Abstract][Full Text] [Related]
20. Performance optimization of the ThinPrep processor: effect of microscope slides.
Lapen DC; Papillo J
Diagn Cytopathol; 1998 Nov; 19(5):388-91. PubMed ID: 9812238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
